| Stage | NXPI | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.8B | 100.00% | $96.2B | 100.00% | NVDA ×25.41 |
| Gross profit | $2.2B | 57.82% | $72.1B | 74.98% | NVDA +17.2pp |
| Operating income | $1.2B | 32.44% | $63.7B | 66.24% | NVDA +33.8pp |
| Pre-tax income | $1.1B | 29.87% | $71.5B | 74.32% | NVDA +44.4pp |
| Net income | $899M | 23.75% | $59.7B | 62.03% | NVDA +38.3pp |
| Stage | NXPI | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $3.8B100.00% | $96.2B100.00% | NVDA ×25.41 |
| Gross profit | 57.82%$2.2B | 74.98%$72.1B | NVDA +17.2pp |
| Operating income | 32.44%$1.2B | 66.24%$63.7B | NVDA +33.8pp |
| Pre-tax income | 29.87%$1.1B | 74.32%$71.5B | NVDA +44.4pp |
| Net income |
| 23.75%$899M |
| 62.03%$59.7B |
| NVDA +38.3pp |
No shared counterparties.